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A series of complexes incorporating Zn(II), Cu(II), and Pd(II) ions, and 4-(5-heptyl-1,3,4-thiadiazol-2-yl)
benzene-1,3-diol (L1) as model ligand, was synthesized in order to examine the nature of potential interactions between biologically active ligands, 1,3,4-thiadiazoles and metal ions with proven biological
relevance. The structures of the compounds isolated were characterized using a number of spectroscopic
methods including IR, Uvevis, AAS, steady state and time-resolved ﬂuorescence (TRF). The results obtained suggest that the L1-Zn(II) and L1-Pd(II) complexes consist of one molecule of L1 and one acetate
ion acting as ligands, while the L1-Cu(II) complex adapts a 2:1 (L1: metal) stoichiometry. The coordination of L1 to metal ions occurs most likely via one of the deprotonated hydroxyl groups of the
resorcinyl moiety and one of the N atoms of the thiadiazole heterocycle.
© 2016 Elsevier B.V. All rights reserved.

Keywords:
Thiadiazole ligand
Complexation
Spectroscopy
Zinc
Copper
Neurodegeneration

1. Introduction
Derivatives of 1,3,4-thiadiazole are a relatively new class of
compounds which demonstrate a broad array of biological activity,
which makes these compounds of interest to a number of ﬁelds in
medicinal chemistry and pharmacology worldwide [1e5]. Due to
their high fungicidal potency against phytopathogenic fungi the
1,3,4-thiadiazole derivatives are considered as potential pesticides
[6]. Also, their signiﬁcant antiproliferative activity against a number
of cancer cell lines has been reported in parallel with the analgesic
and antinociceptive properties [7]. Several other properties of
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thiadiazole derivatives such as their solvatomorphism, crystal
structures, dual ﬂuorescence emission, molecular organization in
lipid membranes and various other solvent-dependent interactions
were extensively studied by our group [5,8e11].
A relatively small number of reports refer to the use of various
thiadiazoles as ligands in the synthesis of biologically active metal
complexes [12e15], which prompted us to carry out a more in
depth study on coordination chemistry of thiadiazole derivatives.
In particular, a recent report has identiﬁed 1,3,4-thiadiazoles as
inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase
(BuChE) [16], enzymes which are responsible for cholinergic deﬁciency and resulting progress of neurodegenerative diseases such
as Alzheimer's [17,18].
The progress of neurodegenerative disorders such as Alzheimer's or Parkinson's disease has been shown to be accompanied
by an altered metal ion homeostasis [19e23]. For instance, the
accumulation of redox-active metal ions, such as Cu(I) and Cu(II), is
responsible for an increased concentration of toxic reactive oxygen
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species (ROS), while the generally redox-inactive Zn(II) ions
interact with amyloid-b proteins (Ab) and induce their aggregation,
leading to the formation Ab plaques. Both ROS and Ab aggregates
are thought to contribute to the progress of neurodegeneration
processes within the brain [24]. Therefore, the design of therapeutic agents with the ability to bind and expel the accumulated
excess metal ions is considered as a promising strategy in the
therapy of neurodegenerative disorders. This in turn requires the
detailed knowledge about the structures of metal complexes,
which may form in vivo as result of the therapeutic action.
The main aim of this work is the structural elucidation
of complexes which may form upon the interaction of thiadiazole
derivatives with metal ions, and especially those involved
in neurodegenerative disorders. In order to examine these structures 4-(5-heptyl-1,3,4-thiadiazol-2-yl)benzene-1,3-diol (L1) was
employed as ligand for the synthesis of Zn(II), Cu(II) and Pd(II)
complexes. The selection of Zn(II) and Cu(II) ions was dictated by
their well-known role of essential trace elements in human physiology as well as their relevance to the progress of neurodegenerative disorders. As the formation of Ab plaques is often
accompanied with coordination of Zn(II) and Cu(II) ions via carboxylic groups [24], simple acetate salts were considered as
convenient source of these ions. The well-known and good catalytic
properties of numerous Pd(II)-based compounds together with the
high potency of some Pd(II) complexes as photosensitizers in
photodynamic therapy [25] were main choice-determining factors
for the selection of Pd(II) ion for this study.

general procedure: the free ligand L1 (200 mg, 0.7 mmol) was
dissolved in hot MeOH (15 ml) and a solution of Zn(II) acetate
(74 mg, 0.35 mmol) in MeOH (10 ml) was added. The mixture was
heated under reﬂux for 3 h. A ﬁne light-yellow solid, which
precipitated upon cooling the mixture was then ﬁltered off, rinsed
with water and air-dried. The crude product was recrystallized
using ACN. The synthesis of L1-Cu(II) complex was carried out in a
similar manner, except that Cu(II) acetate was used and the mixture
was heated to reﬂux and stirred for 1.5 h. The L1-Pd(II) complex was
synthesized in a similar manner, using Pd(II) acetate as a source of
the Pd(II) ions and ACN as solvent in which the reaction mixture
was heated to reﬂux while stirring for 6 h (See Supplementary
Material for experimental details).

2. Materials and methods

The CHN analyses of both L1-Zn(II) and L1-Pd(II) complexes
suggest a structure consisting of one L1 ligand molecule and one
acetate ion being bound to the central metal and such a structure is
supported by NMR spectroscopic data. In the L1-Cu(II) complex, the
Cu: L1 ratio of 1:2 suggest the lack of an acetate ion in the complex.
The proposed structures are supported by the AAS results with only
one L1 molecule in the L1-Zn(II) complex, while there are two L1
ligands in the L1-Cu(II) complex (Fig. 1). All complexes were isolated with high yields. Sharp melting points of the complexes give
evidence for their high purities (See Supplementary Material).

All solvents were of 99% purity or higher (HPLC grade). Methanol (MeOH), acetonitrile (ACN) were purchased from Rathburn
Chemicals (UK). DMSO-d6 and Zn(CH3COOH)2 were purchased
from Sigma (Germany), Cu(CH3COOH)2 was purchased from
Avantor (Poland), and Pd(CH3COOH)2 was purchased from ABCR
(Germany).
The NMR spectra, were acquired on a Bruker Avance III spectrometer (500 MHz), using DMSO-d6 as solvent. Signal assignments
were made using standard techniques including DEPT/COSY/HSQC/
HMBC experiments. The infrared spectra were recorded in the region of 4000 cm1 to 600 cm1 on a Nicolet Impact 410 FourierTransform Infrared spectrophotometer equipped with the ATR
adapter and Omnic software. The electronic absorption spectra
were recorded on a Cary 50 Bio (Varian, USA) spectrophotometer.
The steady state emission spectra were measured on a Fluorolog
Max-P spectroﬂuorometer (Horiba Jobin Yvon, Japan) in MeOH
using the excitation wavelengths equal to the absorption maxima of
the compounds tested and concentration of 0.005 g/l. The ﬂorescence lifetimes tﬂ were measured on a time-domain Chronos BH
ﬂuorometer (ISS, USA) using a laser diode (374 nm, pulse duration
of 42 ps, output power of 1070 mW, and frequency of 10 MHz) for
the excitation, and a H7422P-50 (Hamamatsu, Japan) photomultiplier was applied to detect emission. A diffraction cuvette was
applied as the reference scattering sample. Fitting of theoretical
curves to the experimental data was performed using the bundled
ISS Vinci software.
3. Synthesis
4-(5-Heptyl-1,3,4-thiadiazol-2-yl)benzene-1,3-diol (L1) was
synthesized according to the previously described procedure [6].
3.1. Synthesis of L1-Zn(II), L1-Cu(II), and L1-Pd(II) complexes
All complexes were synthesized according to the following

4. Results and discussion
Although the synthesis and structure of L1 has been reported
[6], its extensive spectroscopic characterization is given in this
work. The structures of free L1 and its complexes were characterized using a number of spectroscopic methods including IR, Uvevis,
AAS, steady state and time-resolved ﬂuorescence (TRF), and NMR
(both 1D and 2D) as well as by elemental analysis (C, H, and N).
Regardless of the numerous attempts made, the isolation of single
crystals suitable for an X-Ray diffraction remained unsuccessful.
4.1. Elemental analysis (CHN) and atomic absorption (AAS)
spectroscopy

4.2. IR spectroscopy
The IR (ATR) spectrum of free L1 (Fig. 2 top), shows a relatively
sharp band at 3345 cm1 and a neighboring, less intensive one at
3220 cm1, assigned to the stretching vibrations of the resorcinyl
eOH groups [16,26]. One of those bands is broadened probably due
to an intramolecular hydrogen bond with one of the thiadiazole
heteroatoms (either S or N). The sharp and moderately intensive
band at 3035 cm1 is assigned to aromatic CeH stretching, while
the aliphatic CeH stretching vibrations manifest as a series of
highly intensive and sharp bands in the region of 2950e2850 cm1.
The most characteristic band, namely the eC]N- stretching vibration of the thiadiazole moiety is present at ~1600 cm1 [6,16]
and is neighbored by three sharp bands at 1520, 1475, and
1434 cm1, assigned to the aromatic CeC stretches of the resorcinyl
moiety. Another pair of sharp and moderately intensive bands at
1342, 1317 cm1 corresponds to an in-plane bending vibrations of
the OeH bond, while the sharp and intensive band at 1276 cm1 is
characteristic of the phenolic CeO stretching vibrations [26]. This
signal is slightly broaden, most likely due to an overlap of two
resorcinyl eOH signals. The series of signals representing CeSeC
stretching of the thiadiazole is present at ~660 cm1 and is
accompanied by a number of other weak signals arising from outof-plane bending vibrations of the hydroxyl OeH bonds [26].
In the spectra of the metallo-complexes (Fig. 2, bottom) the
region of 3400e3000 cm1 is dominated by one broad band, with
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Fig. 1. Structure of 4-(5-Heptyl-1,3,4-thiadiazol-2-yl)benzene-1,3-diol (L1) free ligand and proposed structures of its corresponding L1-Zn(II), L1-Pd(II), and L1-Cu(II) complexes
(M¼Zn(II), or Pd(II)). The structure of L1 shows the numbering system of carbons used for the spectroscopic characterization.

Fig. 2. FT-IR (ATR) spectra of free ligand L1 (top) and its corresponding L1-Zn(II) complex (bottom).

the maxima at 3107, 3117, 3158 cm1 in L1-Zn(II), L1-Cu(II), and L1Pd(II), respectively. This, together with the practically unchanged
aliphatic CeH stretching vibrations, suggests that the complexation
takes place near the resorcinyl ring. This assignment is supported
by the shifts of the bands arising from aromatic CeC stretching,
which in the free L1 have maxima at 1475 and 1434 cm1. In the L1Zn(II) complex these bands are shifted to 1465 and 1412 cm1,
while in the L1-Cu(II) and L1-Pd(II) complexes these changes are
even more signiﬁcant. Both L1-Cu(II) and L1-Pd(II) complexes show
in this region a strong and sharp band at ~1460 cm1, and a pair of
sharp signals within the range of 1550e1500 cm1. Also the thiadiazole ring is strongly affected by the complexation, which manifests in broadening of eC]N- stretching signal. Additionally, the
maximum of this band is shifted from 1601 to 1620, 1606, and
1604 cm1, in of L1-Cu(II) and L1-Pd(II), and L1-Zn(II) complexes,
respectively.
Based on guidelines established by Deacon et al. [27,28], it was
expected for the L1-Zn(II) and L1-Pd(II) complexes that the presence of an acetate ion would give rise to a symmetrical
and asymmetrical stretching vibrations, which are usually
seen between 1600 and 1400 cm1. Due to a signiﬁcant broadening
of the eC]N- stretching vibration and high intensity of the aromatic CeC stretching bands the assignment and examination of
acetate-related signals remained unsuccessful. Nevertheless, an

incorporation of the acetate ligand is conﬁrmed by NMR spectroscopy and supported by results of CHN and AAS analyses.
4.3. NMR spectroscopy
The 1H NMR spectrum of the free ligand in DMSO-d6 (Fig. 3)
consists of ﬁve signals in the downﬁeld region, assigned to the
resorcinyl moiety. The two most downﬁeld-positioned peaks are
singlets assigned to the phenolic eOH groups present at C11 and
C13 carbons. The origin of both eOH signals is additionally
conﬁrmed by D2O exchange experiment (not shown) [26]. The
remaining signals present in the aromatic region are assigned to the
phenolic ring protons at the positions 12, 14, and 15. The doublet at
9.99 ppm with the coupling constant J ¼ 8.62 Hz represents the C15
atom, while the one at 6.47 ppm with J ¼ 2.23 originates from the
C12 proton. The coupling of both C15 and C12 to C14 results in its
signal present as double doublet at 6.41 ppm with J1 and J2 values
correlated with the respective protons coupled. The upﬁeld region
of the spectrum is occupied by a series of signals arising from the
aliphatic chain of the heptyl residue. The triplet at 3.05 ppm is the
most “deshielded” aliphatic signal and is assigned to the C7
methylene group. It couples to neighboring C6 methylene with
J ¼ 7.55 Hz, which is additionally split as result of coupling to
another methylene group C5, giving rise to a quintet at 1.73 ppm.
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Fig. 3. 1H NMR (DMSO-d6) spectra of free 4-(5-Heptyl-1,3,4-thiadiazol-2-yl)benzene-1,3-diol ligand L1 (bottom) and its corresponding L1-Zn(II) complex (top).

The chemical shift of the C5 methylene group is similar to those of
C2eC4, and effects in a multiplet of overlapped signals in the range
of 1.4e1.2 ppm. Hence their assignment is based mainly on COSY
and HSQC correlation experiments (see Supplementary Material)
and additionally supported by integration of the 1HNMR peaks. The
triplet at 0.86 ppm arises from a terminal eCH3 group of the heptyl
chain.
In the spectrum of the L1-Zn(II) complex all peaks are signiﬁcantly broaden, most likely as a result of coordination to the Zn(II)
ion. However, all signal-to-noise ratios remain high and the correct
assignment is possible with support from additional experiments
such as COSY, HSQC and HMBC correlations (Figs. 3 and 4, and
Supplementary Material). The broadening of aromatic peaks is
particularly strong, indicating coordination of the zinc ion is likely
via the resoricnyl residue. In addition, compared to the spectrum of
free ligand, all signals are shifted to lower frequencies and only one
eOH signal is observed. The most signiﬁcant shielding effect is
observed for the aromatic protons, signals, which together with the
disappearance of one of the eOH peaks suggests that the
complexation with L1 occurs most likely via one of the hydroxyl
groups and one of the thiadiazole N atoms (Fig. 1). A new signal
present in the aliphatic region of the spectrum, namely the sharp
singlet at 1.83 ppm is characteristic of the eCH3 group of the acetate [29] and shows a long range correlation (HMBC) with characteristic highly de-shielded carboxylic carbon (Fig. 4 D). This
suggests an involvement of the acetate in the complexation and is
consistent with the AAS and IR spectroscopic data as well as with
the elemental analysis results.
The 13C NMR signals of the ligand are even more strongly
affected by the presence of central metal ion compared to the
corresponding protons in the 1H NMR spectrum. The 13C NMR
spectrum of L1-Zn(II) complex (Fig. 4 A and Supplementary
Material) does not give a full set of expected signals as only the
aliphatic C1eC7 and the acetate carbons are clearly visible. The
assignment of C1eC7 carbons is additionally supported by the
DEPT (D135), HSQC and HMBC experiments (Fig. 4 B, C, and D, and
Supplementary Material). The carbons that constitute the aromatic
and heterocyclic ring give extremely weak signals and their
assignment is made based mainly on the 2D correlation spectroscopy. The aromatic C12, C14, and C15 carbons are assigned based on
HSQC spectrum (Fig. 4C). Neither does the HMBC correlation give a
spectrum of satisfactory quality and only aliphatic signals gave rise

to strong cross-signals (Fig. 4 D). Nevertheless, the HMBC spectrum
allows for the assignment of the C8 carbon of the thiadiazole and
gives evidence for the acetate ion present in the L1-Zn(II) complex,
by showing the long distance interaction between singlet at
1.83 ppm and highly de-shielded carboxylic carbon at 176.74 ppm
(Fig. 4D). Chemical shifts of the remaining four quaternary carbons,
namely the C9-11 and C13, were calculated using the available
tabular data [26].
Low solubility of the L1-Pd(II) is a major obstacle in the acquisition of satisfactory quality 1H NMR spectrum of this complex (not
shown). In spite of the signiﬁcant broadening of all signals, a
pattern of chemical shifts similar to that of the Zn(II) complex is
observed. The structural similarity to L1-Zn(II), including the
presence of the acetate ion is in agreement with the results obtained from the IR and CHN analyses. Due to the solubility problems, the acquisition of 13C NMR spectrum of L1-Pd(II) was not
feasible.
4.4. UVevis absorption spectroscopy
The electronic absorption spectra of free ligand and its metallocomplexes are shown in Fig. 5. The spectrum of free ligand consists
of two intense p / p* transition bands with their maxima at
l1 ¼ 286 and l2 ¼ 318 nm. Coordination to L1-Zn(II) and L1-Cu(II)
ions results in only a slight bathochromic shift of the l1 (287 and
288 nm, respectively), while in L1-Pd(II) complex this band is
signiﬁcantly shifted towards higher energy (265 nm). In all complexes, l2 shifts hipsochromically from 318 nm (free ligand) to 316,
303, and 305 nm, in L1-Zn(II), L1-Cu(II), and L1-Pd(II) complex,
respectively. The formation of complexes manifests most notably
by new absorption bands l3 appearing at the lower energy side of
the spectra, with the absorption maxima at 363, 365, and 378 nm,
respectively. Additionally, the d / d* transitions l4 are visible in
the spectra of L1-Cu(II) and L1-Pd(II) complexes as low intensity
broad bands centered at approximately 660 and 580 nm,
respectively.
4.5. Steady state and time-resolved ﬂuorescence spectroscopy
The ﬂuorescence spectrum of each compound consists of only
one emission band, with the maximum at approximately 440 nm
(Fig. 6). Although there are no signiﬁcant differences between the
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Fig. 4. Assignment of 13C NMR signals in the L1-Zn(II) complex: A) 13C NMR spectrum of free ligand L1 (bottom) v.s. L1-Zn(II) complex (top); B) Aliphatic region of
spectrum of L1-Zn(II) complex (bottom) v.s. DEPT (D135) (top); C) HSQC spectrum of L1-Zn(II) complex; D) HMBC spectrum of L1-Zn(II) complex.

13

C NMR

Fig. 6. Steady state ﬂuorescence spectra of free L1 and its metal complexes in MeOH.
Fig. 5. UVeVis spectra of free L1 ligand and its corresponding metal complexes in
MeOH. All spectra are normalized to the a.u. value of 1 at the l2 maxima.

positioning of emission maxima, the intensities vary widely
depending on type of the central metal ion. The greatest emission
intensity is observed in the L1-Zn(II) complex, while the emission
from L1 is less intensive. The lower intensity of ﬂuorescence
emission in the free ligand may have several reasons, including the
possibility of free rotation (cis-trans isomerization), intramolecular
rearrangements, or various structural distortions, which may
contribute to non-radiative relaxation [30e32]. Moreover, the
hydrogen bonding or other interactions with environment (solvent), may additionally favor a non-radiative dissipation of the
excitation energy [33]. Coordination with metal ions utilizes a
number of substituents able to form hydrogen bonds, thus disfavoring the non-radiative dissipation of the excitation energy.
Also, the formation of complex effects in an increased rigidity of the
whole molecule which usually results in an increase in the ﬂuorescence intensity. Additionally, the electron-reach metal ions such
as Zn(II), with fully occupied d valence orbital and relatively low
mass prefer most likely the radiative relaxation pathway rather
than non-radiative one. The opposite effect is observed in the L1Cu(II) and L1-Pd(II) complexes, in which emission of ﬂuorescence

is strongly quenched. Compared to those of L1-Zn(II), and free L1
ligand, the weak ﬂuorescence of L1-Cu(II) complex may be as result
of internal conversion from the excited MLCT state [34], while in L1Pd(II) results most likely form an increased spin-orbit coupling,
which favors the relaxation via intersystem crossing (ISC) [35].
Most compounds show monoexponential ﬂuorescence decays,
except the L1-Pd(II) complex (Fig. 7), which shows a multi exponential decay and which may be associated with the sample scattering caused by the poor solubility, which in turn may result in an
incorrect identiﬁcation of its intrinsic decay kinetics [36]. L1 has the
longest ﬂuorescence lifetime of 2.95 ns. Among the complexes the
L1-Zn(II) has the longest ﬂuorescence lifetime (2.76 ns), which is
only slightly shorter than that of the free ligand (Table 1). The
ﬂuorescence lifetime of L1-Cu(II) complex is shorter by 1 ns than
that of L1, while the results obtained for L1-Pd(II) are unreliable.
5. Conclusions
In conclusion, we have synthesized a series of metal complexes
with 4-(5-heptyl-1,3,4-thiadiazol-2-yl)benzene-1,3-diol (L1). Based
on the set of spectroscopic experiments we were able to propose
the structures of the complexes, which adapt a distorted square
planar or tetrahedral coordination geometry. The spectroscopic
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Fig. 7. Fluorescence decays of free L1 and its corresponding metal complexes in MeOH.

Table 1
Absorption and emission maxima and ﬂuorescence lifetimes of free L1 and its corresponding metal complexes in MeOH.
Compound

lAbs [nm]

lEm (lEx) [nm]

tﬂ [ns]

L1 free ligand

286
318
287
316
363
288
303
365
650
265
305
378
580

442 (365)

2.95

440 (365)

2.76

430 (365)

1.92

L1eZn (II) complex

L1eCu (II) complex

L1ePd (II) complex

observed for a number of other potential AChE inhibitors [37]. The
high yields and purities of complexes enable the possibility of
further studies aimed at more detailed examination of their biological activity.
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430 (365)
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